Phase I/II Study of Docetaxel, Cisplatin and 5-Fluorouracil(TPF) as Chemotherapy in Pre-Treated Patients With Metastatic Esophageal Cancer.

Trial Profile

Phase I/II Study of Docetaxel, Cisplatin and 5-Fluorouracil(TPF) as Chemotherapy in Pre-Treated Patients With Metastatic Esophageal Cancer.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 25 May 2010

At a glance

  • Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Fluorouracil (Primary)
  • Indications Oesophageal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Feb 2009 Planned end date changed from 1 Nov 2008 to 1 Nov 2009 as reported by ClinicalTrials.gov.
    • 16 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top